Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884307 · ClinicalTrials.gov registry record · NA
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
A NA study of Gender Dysphoria, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 1
- Study location
NCT05884307 is a NA study of Gender Dysphoria that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 138 participants, below the 161-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05884307, a NA study of Gender Dysphoria, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 1 is a feasibility and acceptability study of the proposed intervention and will enroll 100 TNB participants to provide feedback to inform a follow-up randomized controlled trial.
Conditions Studied
Interventions
- OTHER Trans Care Web App
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2024-05-23 |
| Est. Completion | 2024-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05884307
The ClinicalTrials.gov registry entry for NCT05884307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 161-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (14% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gender Dysphoria appearing as the primary indexed condition, and to 1 intervention - of which Trans Care Web App is the first listed.
NCT05884307 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05884307 about?
NCT05884307 is a clinical study titled "Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria". The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules ...
What is the current status of trial NCT05884307?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2024-05-23. Estimated completion is 2024-08-28.
What conditions does trial NCT05884307 study?
This clinical trial studies the following conditions: Gender Dysphoria.
What interventions are being tested in trial NCT05884307?
The interventions under investigation include: Trans Care Web App (OTHER).
Who is sponsoring clinical trial NCT05884307?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05884307 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Dysphoria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
RECRUITING
-
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Effect of Nitropaste in Chest Masculinizing Surgery
RECRUITING · Phase 4
-
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.